Introduction to Radiation Biology When Treating Hyperproliferative Benign Diseases



Fig. 45.1
Model of target cells and involved factors. Advanced model of target cells and factors involved in the therapeutic modulation of hyperproliferative/fibrotic benign diseases by a low-dose radiation therapy. Upon fibrotic activation by TGF-β1 and other factors, progenitor fibroblasts will be activated to form myofibroblast/fibrocyte that in turn increase deposition of ECM compounds. Ionizing radiation may interfere with this process by eliminating radiosensitive mitotic fibroblasts, forcing differentiation of fibroblasts, induction of free radicals, modulation of cytokine production and endothelial cell and macrophage activity. Abbreviations are given in the text





Acknowledgements and Conflict of Interest Statement

This work has received funding from the European Atomic Energy Community’s Seventh Framework Programme under grant agreement no FP7-249689 (European Network of Excellence, DoReMi) and the German Federal Ministry of Education and Research (GREWIS, 02NUK017F). The authors have no conflict of interest to declare.


References



Abraham DJ, Eckes B, Rajkumar V, Krieg T (2007) New developments in fibroblast and myofibroblast biology: implications for fibrosis and scleroderma. Curr Rheumatol Rep 9(2):136–143PubMed


Alioto RJ, Rosier RN, Burton RI, Puzas JE (1994) Comparative effects of growth factors on fibroblasts of Dupuytren’s tissue and normal palmar fascia. J Hand Surg Am 19(3):442–452PubMed


Alman BA, Naber SP, Terek RM et al (1995) Platelet-derived growth factor in fibrous musculoskeletal disorders: a study of pathologic tissue sections and in vitro primary cell cultures. J Orthop Res 13(1):67–77PubMed


Andrew JG, Andrew SM, Ash A, Turner B (1991) An investigation into the role of inflammatory cells in Dupuytren’s disease. J Hand Surg Br 16(3):267–271PubMed


Badalamente MA, Sampson SP, Hurst LC et al (1996) The role of transforming growth factor beta in Dupuytren’s disease. J Hand Surg Am 21(2):210–215PubMed


Bayreuther K, Francz PI, Rodemann HP (1992) Fibroblasts in normal and pathological terminal differentiation, aging, apoptosis and transformation. Arch Gerontol Geriatr 15(Suppl 1):47–74PubMed


Bayreuther K, Rodemann HP, Francz PI, Maier K (1988a) Differentiation of fibroblast stem cells. J Cell Sci Suppl 10:115–130PubMed


Bayreuther K, Rodemann HP, Hommel R et al (1988b) Human skin fibroblasts in vitro differentiate along a terminal cell lineage. Proc Natl Acad Sci U S A 85(14):5112–5116PubMedPubMedCentral


Berndt A, Kosmehl H, Katenkamp D, Tauchmann V (1994) Appearance of the myofibroblastic phenotype in Dupuytren’s disease is associated with a fibronectin, laminin, collagen type IV and tenascin extracellular matrix. Pathobiology 62(2):55–58PubMed


Bianchi E, Taurone S, Bardella L et al (2015) Involvement of pro-inflammatory cytokines and growth factors in the pathogenesis of Dupuytren’s contracture: a novel target for a possible future therapeutic strategy? Clin Sci (Lond) 129(8):711–720


Bumann J, Santo-Holtje L, Loffler H, Bamberg M, Rodemann HP (1995) Radiation-induced alterations of the proliferation dynamics of human skin fibroblasts after repeated irradiation in the subtherapeutic dose range. Strahlenther Onkol 171(1):35–41PubMed


Cordova A, Tripoli M, Corradino B et al (2005) Dupuytren’s contracture: an update of biomolecular aspects and therapeutic perspectives. J Hand Surg Br 30(6):557–562PubMed


Dolmans GH, Werker PM, Hennies HC et al (2011) Wnt signaling and Dupuytren’s disease. N Engl J Med 365(4):307–317PubMed


Fitzgerald AM, Kirkpatrick JJ, Naylor IL (1999) Dupuytren’s disease. The way forward? J Hand Surg Br 24(4):395–399PubMed


Gabbiani G, Ryan GB, Majne G (1971) Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 27(5):549–550PubMed


Grenfell S, Borg M (2014) Radiotherapy in fascial fibromatosis: a case series, literature review and considerations for treatment of early-stage disease. J Med Imaging Radiat Oncol 58(5):641–647PubMed

Oct 4, 2017 | Posted by in ORTHOPEDIC | Comments Off on Introduction to Radiation Biology When Treating Hyperproliferative Benign Diseases

Full access? Get Clinical Tree

Get Clinical Tree app for offline access